VBI Vaccines Stock Target Price and Analyst Consensus
| VBIV Stock | USD 0.61 0.01 1.67% |
The current analyst and expert consensus on VBI Vaccines is Buy, with no strong buy opinions. The current projected VBI Vaccines target price consensus is 4.00 with 1 analyst opinions. The most common way VBI Vaccines analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview VBI Vaccines executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on VBI Vaccines. We encourage you to use your own analysis of VBI Vaccines to validate this buy or sell advice. VBI Vaccines buy-or-sell recommendation module provides average expert sentiment on the projected VBI Vaccines target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on VBI Vaccines to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.
Lowest Forecast 3.64 | Highest Forecast 4.44 | Target Price 4 |
VBI |
It's important to approach VBI Vaccines' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize VBI Vaccines price targets
VBI Vaccines' stock target price is an estimate of its future price, usually made by analysts. Using VBI Vaccines' target price to determine if it is a suitable investment can be done through the following steps:- Look at VBI Vaccines' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if VBI Vaccines' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional VBI Vaccines Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of VBI Vaccines is a key component of VBI Vaccines valuation and have some predictive power on the future returns of a VBI Vaccines.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of VBI Vaccines' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Cash Cows Invested a lot of shares | |
 | Manufacturing Invested over 40 shares | |
 | Banking Invested over 50 shares | |
 | Artificial Intelligence Invested few shares | |
 | Hedge Favorites Invested over 70 shares | |
 | Investor Favorites Invested over 200 shares | |
Check out Macroaxis Advice on VBI Vaccines to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for VBI Stock analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
The data published in VBI Vaccines' official financial statements usually reflect VBI Vaccines' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of VBI Vaccines. For example, before you start analyzing numbers published by VBI accountants, it's critical to develop an understanding of what VBI Vaccines' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of VBI Vaccines' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, VBI Vaccines' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in VBI Vaccines' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of VBI Vaccines. Please utilize our Beneish M Score to check the likelihood of VBI Vaccines' management manipulating its earnings.